Webinar: Assessing Clinical and Economic Benefits of Biocomputational Models

27 March 2012, 09:00 PDST/13:00 EST/18:00 CEST (UTC +02:00).
The economic assessment method described reflects the latest research from the NMS Physiome project, a cooperation of two of the largest global research projects focusing on predictive, personalised and integrative musculoskeletal medicine: the Osteoporotic Virtual Physiological Human (VPHOP) project, and the Center for Physics-based Simulation of Biological Structures (SIMBIOS) at Stanford University.

The Virtual Physiological Human (VPH) is a framework of methods and technologies that, once fully established, is expected to make possible the virtual investigation of the human body as a whole. Started in Europe in 2005, it has rapidly grown to become one of the research priorities of the Information and Communication Technologies Programme of the EU Seventh Framework Programme for Research and Technological Development, which runs from 2007 to 2013. In the US, VPH-type research is funded by all the federal agencies that participate in the Interagency Modeling and Analysis Group (IMAG), whose grantees are coordinated in the Multi-Scale Modeling (MSM) consortium.

NMS Physiome is an international project co-funded by the European Commission Seventh Framework Programme for Research and Technological Development. The Webinar is hosted by SIMBIOS, Stanford University.

How do you assess the impact of biocomputational models?
Karl Stroetmann and Rainer Thiel, empirica Communication and Technology Research, Bonn, Germany.

In this webinar, you will learn about general principles to evaluate the prospective economic and clinical benefits of simulation methods. Webinar organisers will show how this approach enables you to:

  • Assess simulation research and translate technical capability into quantitative estimates of costs and benefits that go beyond model validation
  • Gain a better understanding about the impact such work can have on future health care service delivery and clinical practice
  • Demonstrate the added value of simulation research through clear measures of clinical benefits and the development of business cases
  • More effectively decide what aspects of the model should be included or excluded

The webinar is targeted at biocomputational modellers and researchers as well as RTD funding agencies in the field of Virtual Physiological Human and Physiome.

Duration: 60 minutes.

To register for the event, please visit:
https://stanford.webex.com/stanford/onstage/g.php?d=925320571&t=a

Most Popular Now

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...